The Enterprise Value as of June 2026 (TTM) for Matinas BioPharma Holdings, Inc. (MTNB) is 3.07M

According to Matinas BioPharma Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.07M. This represents a change of 20.36% compared to the average of 2.55M of the last 4 quarters.

Matinas BioPharma Holdings, Inc. (MTNB) Historical Enterprise Value (quarterly & annually)

How has MTNB Enterprise Value performed in the past?

The mean historical Enterprise Value of Matinas BioPharma Holdings, Inc. over the last ten years is 113.77M. The current 3.07M Enterprise Value has changed 170.09% with respect to the historical average. Over the past ten years (40 quarters), MTNB's Enterprise Value was at its highest in in the December 2019 quarter at 351.60M. The Enterprise Value was at its lowest in in the December 2024 quarter at -1908427.21.

Matinas BioPharma Holdings, Inc. (MTNB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Matinas BioPharma Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Matinas BioPharma Holdings, Inc. (MTNB) Average Enterprise Value

How has MTNB Enterprise Value performed in the past?

The current Enterprise Value of Matinas BioPharma Holdings, Inc. (MTNB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Matinas BioPharma Holdings, Inc. (MTNB) Enterprise Value vs. Peers

How is MTNB’s Enterprise Value compared to its peers?

Matinas BioPharma Holdings, Inc.’s Enterprise Value is less than Brainstorm Cell Therapeutics Inc. (9.75M), less than NeuroSense Therapeutics Ltd. (18.14M), less than Impact BioMedical Inc. (7.29M), less than Addex Therapeutics Ltd (4.62M), greater than Adial Pharmaceuticals, Inc. (-1724361.00), greater than Cardio Diagnostics Holdings, Inc. (-2485596.00), greater than VYNE Therapeutics Inc. (-13823812.00), less than HCW Biologics Inc. (8.02M), greater than Pasithea Therapeutics Corp. (-46001320.00), greater than Acurx Pharmaceuticals, Inc. (-6766398.00),

Build a custom stock screener for Matinas BioPharma Holdings, Inc. (MTNB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Matinas BioPharma Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Matinas BioPharma Holdings, Inc. (MTNB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Matinas BioPharma Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.